Article Details
Retrieved on: 2022-06-02 17:07:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SOUTH SAN FRANCISCO, Calif. , June 02, 2022 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage ...
Article found on: www.marketscreener.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here